172 related articles for article (PubMed ID: 17630012)
1. Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
Fujita M; Lee BS; Khazenzon NM; Penichet ML; Wawrowsky KA; Patil R; Ding H; Holler E; Black KL; Ljubimova JY
J Control Release; 2007 Oct; 122(3):356-63. PubMed ID: 17630012
[TBL] [Abstract][Full Text] [Related]
2. Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery.
Lee BS; Fujita M; Khazenzon NM; Wawrowsky KA; Wachsmann-Hogiu S; Farkas DL; Black KL; Ljubimova JY; Holler E
Bioconjug Chem; 2006; 17(2):317-26. PubMed ID: 16536461
[TBL] [Abstract][Full Text] [Related]
3. Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer.
Inoue S; Patil R; Portilla-Arias J; Ding H; Konda B; Espinoza A; Mongayt D; Markman JL; Elramsisy A; Phillips HW; Black KL; Holler E; Ljubimova JY
PLoS One; 2012; 7(2):e31070. PubMed ID: 22355336
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis.
Fujita M; Khazenzon NM; Ljubimov AV; Lee BS; Virtanen I; Holler E; Black KL; Ljubimova JY
Angiogenesis; 2006; 9(4):183-91. PubMed ID: 17109197
[TBL] [Abstract][Full Text] [Related]
5. Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
Inoue S; Ding H; Portilla-Arias J; Hu J; Konda B; Fujita M; Espinoza A; Suhane S; Riley M; Gates M; Patil R; Penichet ML; Ljubimov AV; Black KL; Holler E; Ljubimova JY
Cancer Res; 2011 Feb; 71(4):1454-64. PubMed ID: 21303974
[TBL] [Abstract][Full Text] [Related]
6. Nanoconjugate based on polymalic acid for tumor targeting.
Ljubimova JY; Fujita M; Khazenzon NM; Lee BS; Wachsmann-Hogiu S; Farkas DL; Black KL; Holler E
Chem Biol Interact; 2008 Jan; 171(2):195-203. PubMed ID: 17376417
[TBL] [Abstract][Full Text] [Related]
7. Natural and synthetic poly(malic acid)-based derivates: a family of versatile biopolymers for the design of drug nanocarriers.
Loyer P; Cammas-Marion S
J Drug Target; 2014 Aug; 22(7):556-75. PubMed ID: 25012064
[TBL] [Abstract][Full Text] [Related]
8. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
[TBL] [Abstract][Full Text] [Related]
9. Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.
Ljubimova JY; Fujita M; Ljubimov AV; Torchilin VP; Black KL; Holler E
Nanomedicine (Lond); 2008 Apr; 3(2):247-65. PubMed ID: 18373429
[TBL] [Abstract][Full Text] [Related]
10. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.
Ljubimova JY; Portilla-Arias J; Patil R; Ding H; Inoue S; Markman JL; Rekechenetskiy A; Konda B; Gangalum PR; Chesnokova A; Ljubimov AV; Black KL; Holler E
J Drug Target; 2013 Dec; 21(10):956-967. PubMed ID: 24032759
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.
Gupta B; Torchilin VP
Cancer Immunol Immunother; 2007 Aug; 56(8):1215-23. PubMed ID: 17219149
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected].
Ding H; Inoue S; Ljubimov AV; Patil R; Portilla-Arias J; Hu J; Konda B; Wawrowsky KA; Fujita M; Karabalin N; Sasaki T; Black KL; Holler E; Ljubimova JY
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18143-8. PubMed ID: 20921419
[TBL] [Abstract][Full Text] [Related]
14. Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation.
Zhang P; Hu L; Yin Q; Zhang Z; Feng L; Li Y
J Control Release; 2012 May; 159(3):429-34. PubMed ID: 22306333
[TBL] [Abstract][Full Text] [Related]
15. Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages.
Almouazen E; Bourgeois S; Boussaïd A; Valot P; Malleval C; Fessi H; Nataf S; Briançon S
Int J Pharm; 2012 Jul; 430(1-2):207-15. PubMed ID: 22465633
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
17. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
Cirstoiu-Hapca A; Bossy-Nobs L; Buchegger F; Gurny R; Delie F
Int J Pharm; 2007 Mar; 331(2):190-6. PubMed ID: 17196347
[TBL] [Abstract][Full Text] [Related]
18. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
[TBL] [Abstract][Full Text] [Related]
19. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma.
Guo W; Li A; Jia Z; Yuan Y; Dai H; Li H
Eur J Pharmacol; 2013 Oct; 718(1-3):41-7. PubMed ID: 24070814
[TBL] [Abstract][Full Text] [Related]
20. Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas.
Wadajkar AS; Dancy JG; Roberts NB; Connolly NP; Strickland DK; Winkles JA; Woodworth GF; Kim AJ
J Control Release; 2017 Dec; 267():144-153. PubMed ID: 28887134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
